Objective This study was conducted to determine the association between gastrointestinal (GI) colonization and the development of invasive Pseudomonasaeruginosa infections and risk factors for acquisition of P. aeruginosa colonization in gut. Methods All stool specimens sent for microbiological examination were cultured for P. aeruginosa search for three years.
Introduction
Pseudomonas aeruginosa (P. aeruginosa) is a ubiquitous organism that thrives in moist environments. In a hospital, typical environmental reservoirs include respiratory equipment, sinks, and water bottles (1, 2) . P. aeruginosa is an important nosocomial pathogen in hospitalized patients because of its ability to colonize and infect the human host (3, 4).
Chronic colonization of the gastrointestinal (GI) mucosa is also acknowledged to be an important component of P. aeruginosa diarrheal disease and systemic infections (5-7).
Since disruption of the normal flora by antibiotics can reduce colonization resistance and promote pathologic colonization with P. aeruginosa (4, 8), enterocolitis due to P. aeruginosa is also considered to be an antibiotic-associated gastroenteritis. However, the role of antibiotics in GI colonization has not been determined. Research to date has determined that colonization has not been statistically associated with exposure to any specific antibiotic treatment, administered alone or in combination (9), and that P. aeruginosa can colonize the GI tract of healthy adults (10). GI colonization is strongly correlated with the development of invasive infection within 1 week of culture for Pseudomonas in an intensive care unit (ICU). ICU mortality was significantly greater for patients colonized with Pseudomonas (4). However, the number of patients who were enrolled in that study was so small (n=10) that the correlation between GI colonization and the development of P. aeruginosa infection was not definitive. Moreover, it is also unknownwhat risk factors favor development of invasive P. aeruginosa infection.
The aim of this study was to analyze patients factors regarding acquisition of colonization in the GI tract and to determine the rate and risk factors of development of invasive infections due to P. aeruginosa in patients displaying GI colonization.
Pseudomonasaeruginosa in GI Tract
Patients and Methods A prospective study of all patients hospitalized in the 1,015-bed tertiary-care teaching hospital of Jichi Medical School was performed for three years (from April 1998 to March 2001). All stool specimens sent to the laboratory for microbiological examination of diarrheal disease and surveillance were cultured for P. aeruginosa. P. aeruginosa isolates were identified by colony morphology and grown at 42°C, and biochemical activity was determined using the API20 NE system (API System, La Balme les Grottes, France).
Colonization was defined as the isolation of P. aeruginosa from two consecutive cultures in the absence of infection with P. aeruginosa. Patients judged to be P. aeruginosacolonized were followed until discharge to determine if they would develop P. aeruginosa infection. A standard questionnaire was used to obtain data. The following data were collected from the patient charts: age, sex, Of the 87 patients, the period of P. aeruginosa colonization in GI tract in 32 could be identified because the stool cultures were conducted periodically for the observation of gut microbial flora. When colonized, ll (34%) patients suffered from ileus, and three (9%) patients underwent gastrostomy (Table 3) . Although 14 (44%) patients displayed no particular events when colonized, the majority experienced abdominal symptoms, such as diarrhea, abdominal p ain and distension.
In colonized patients, P. aeruginosa was isolated from the following body sites in addition to the GI tract: respiratory tract (38%), skin (16%), urinary tract (14%), throat (13%), and nose (10%) ( and duration of hospitalization were 53.8 years and 84.5 days. Males and females were almost evenly divided and seven patients were exposed to invasive procedures. Nostatistically significant correlation was observed between the acquisition of infection and age, gender, underlying disease, previous invasive procedure, or duration of hospitalization. Discussion P. aeruginosa is commonly harbored in hospital surroundings and often contaminates patient samples. Verweij and coworkers reported a pseudo-outbreak of P. aeruginosa fecal colonization due to improper sampling technique (ll). Therefore, isolation of P. aeruginosa from stool does not necessarily reflect P. aeruginosa colonization of the GI tract.
In thepresent study, 87 inosa colonization, as this organism is strictly aerobic. It was previously observed that P. aeruginosa is rarely recovered from the GI tract of patients with cystic fibrosis when the respiratory tract is culture-negative (5, 6). P. aeruginosa was recovered from the respiratory tract of 24 of 87 patients with colonization of the gut in the present study. This detection rate from the respiratory tract may be considered low, but may in fact reflect a natural level because respiratory cultures had not been conducted in all patients with colonization in the GI tract. Other colonized sites were skin, urinary tract, throat and nose. Thirteen of 87 (15%) patients developed invasive P. aeruginosa infection.
Respiratory and urinary infections were dominant, followed by wound infection and sepsis. In one study of ICU patients, 90% of patients with P. aeruginosa colonization of the GI tract developed invasive infection within 1 week of culture for the bacterium (4). This discrepancy in the development rate of invasive infection may be due to the patient conditions, as this organism more readily colonizes the sickest patients and causes invasive infection (4). Bonten and co-workers reported that 16% of colonized patients developed an infection (15). Our data support their result.
What strategies should be practiced when P. aeruginosa is isolated from stool samples? Currently, many physicians ignore P. aeruginosa isolated from stool. This organism is rarely considered to cause diarrheal diseases, although it has been well documented to produce disease in the GI tract, from the oropharynx to the rectum, particularly in young children, cancer patients, and immunocompromised patients (16-18). In the present study, no risk factors for the development of P. aeruginosa invasive infection were determined. We recommend that all patients colonized with P. aeruginosa in the GI tract should not be given antipseudomonal agents, because only 15% of colonized patients presented with invasive infection in the present study. Furthermore, the use of antimicrobial therapy is considered a risk factor for the emergence and spread of bacteria resistant to antimicrobial agents (19), and definitive evidence that a P.
aeruginosa 
